Boston Scientific Launches Trial to Evaluate Neurostimulation for Treatment of Chronic Migraine

Boston Scientific Launches Trial To Evaluate Neurostimulation For Treatment Of Chronic Migraine (via PR Newswire)

First Patient Treated in OPTIMISE Clinical Trial Evaluating Safety, Efficacy of Occipital Nerve Stimulation Using Precision™ System NATICK, Mass., July 19, 2013 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has launched a clinical trial…